Hypertension affects approximately 20 to 30% of individuals in industrialized countries, and is commonly believed to develop on the basis of both genetic and environmental factors. The identification of genes susceptibile to the most frequent form of hypertension, commonly referred to as "essential" hypertension, is hampered by the fact that blood pressure is a poorly defined phenotype that is modulated by multiple factors, such as gender, race, body mass etc., and that the definition of hypertension depends on a rather arbitrarily chosen cut-off value. Hence, more progress has been made in the identification of genes responsible for rare autosomal dominant forms of hypertension, such as Liddle's disease. This review focuses on an experimental approach that attempts to define candidate genes for essential hypertension using immortalized cells from well characterized normotensive and hypertensive subjects. From the presently available results, one attractive speculation is that an increased intracellular signal transduction caused by an enhanced reactivity of G i -type G proteins represents a genetically fixed trait that renders affected individuals susceptible to essential hypertension.
It is generally agreed that essential hypertension is a multifactorial polygenetic disorder [1, 2] . Current research efforts aim at identifying those genes that increase the susceptibility for hypertension either alone or in combination with other genes and/or environmental factors.
Several quite different experimental strategies exist to identify such "hypertension genes." One involves the examination of rare autosomal dominant forms of hypertension, such as Liddle's disease, which is caused by mutations in the ␤ or ␥ subunits of the epithelial sodium channel [3, 4] . Schuster et al focused their investigations on a Turkish family with severe autosomal dominant hypertension that cosegregates 100% with brachydactyly and maps to chromosome 12p [5] . Interestingly, this form of hypertension, despite very early onset and steep increase in blood pressure, resembles the common form of essential hypertension [6] , and identification of the responsible gene(s) in that Turkish kindred therefore can be expected to be of major importance for understanding the genetic basis of essential hypertension. Other strategies rely predominantly on genetic linkage analysis, which has led to the identification of a common M235T variant in the gene encoding for angiotensinogen [7] .
Animal models of hypertension are very useful for the identification of hypertension genes, as illustrated by the recent findings of Cusi et al [8] . These authors could identify a polymorphism in the ␣-adducin gene that is tightly associated with salt sensitivity in patients with essential hypertension. Originally, this protein was identified as a possible candidate gene in the Milan hypertensive strain of rats, and mutations within the adducin genes were shown to be associated with blood pressure variations in these animals [9] .
Finally, one method that remains very useful in defining genes susceptible to hypertension consists of the "classical" candidate gene approach. This method depends on the careful characterization of intermediate phenotypes in essential hypertension, that is, traits that are obviously inherited and tightly linked to, but not necessarily directly involved in the pathogenesis of essential hypertension.
This review will focus on our attempts to identify novel hypertension candidate genes.
NA ؉ /H ؉ EXCHANGER ACTIVITY AS AN INTERMEDIATE PHENOTYPE IN ESSENTIAL HYPERTENSION
The Na ϩ /H ϩ exchanger isoform-1 (NHE-1) is a ubiquitously expressed ion transport protein that mediates electroneutral exchange of extracellular Na ϩ ions against intracellular protons, thereby contributing to intracellular pH homeostasis. Most likely this protein also mediates Na ϩ /Li ϩ countertransport [10, 11] , which constitutes an established genetic marker for hypertension [12, 13] . Multiple studies have shown that the activity of the Na ϩ /H ϩ exchanger isoform-1 (NHE-1) is enhanced in a group of patients with essential hypertension, and this enhancement of NHE activity was found in all cells and tissues investigated, such as erythrocytes, platelets, lymphocytes, and even skeletal muscle in vivo [reviewed in 14 -16] . However, the activity of the NHE-1 is known to be increased in vitro by phosphorylation and Ca 2ϩ -calmodulin-mediated reactions upon cell activation via G proteincoupled receptors and receptors with tyrosine kinase activity [17, 18] . Furthermore, NHE-1 activity in vivo is enhanced by multiple influences, such as metabolic acidosis [19, 20] , oral glucose uptake [21] , acute saline infusion [22, 23] , and chronic NaCl loading [24] , to name but a few. Thus, it has been impossible to draw definitive conclusions regarding the ultimate cause of enhanced NHE-1 activity in essential hypertension, and it is conceivable that this phenomenon is just another reflection of an altered neurohumoral milieu in essential hypertension. Therefore, we decided to approach the question of whether or not enhanced NHE-1 activity is a genetically fixed abnormality in essential hypertension by using a novel experimental approach. We immortalized lymphocytes from normotensive and hypertensive subjects with low and high NHE-1 activity in platelets and lymphocytes, respectively, using Epstein Barr virus (EBV). This resulted in the establishment of permanently growing B lymphoblast cultures, which could then be treated identically under standard cell culture conditions and yet never be in contact with the hypertensive in vivo milieu. We then demonstrated that the original cellular phenotypes of low and high NHE-1 activity were preserved in these immortalized cell lines [25], a finding that was confirmed in an independent study [26] . This enhanced NHE-1 activity was strongly associated with an enhanced proliferation of these respective cell lines [25] and a faster passage through the cell cycle [27] . Subsequent studies have been aimed at identifying the molecular mechanisms underlying this ion transport abnormality. A mutation in the NHE-1 gene could not be detected upon direct sequencing of the encoding cDNA [25] , and an overexpression of the NHE-1 both on the mRNA as well as the protein level could be ruled out [25, 26] . However, the phosphorylation state of both the NHE-1 protein and the mitogen-activated protein kinase (MAP kinase) was significantly increased in these "hypertensive" cell lines [28] , which pointed to a more "general" abnormality in intracellular signal transduction in these cell lines that was presumably located upstream of MAP kinase and NHE-1 control. We therefore focused subsequent experiments on the characterization of intracellular signal transduction in these immortalized lymphoblasts from normotensive and hypertensive subjects.
ENHANCED ACTIVATION OF G PROTEINS IN "HYPERTENSIVE" B LYMPHOBLAST CELL LINES
Upon stimulation of B lymphoblasts with platelet-activating factor (PAF), there were distinct increases in intracellular Ca 2ϩ in cells from hypertensive subjects with high NHE-1 activity compared to cells from normotensive controls with normal NHE-1 activity [29] . These enhanced Ca 2ϩ signals resulted from an enhanced PAF-evoked formation of inositol-1,4,5-trisphosphate, that is, the second messenger that releases Ca 2ϩ from intracellular stores. Furthermore, PAF-stimulated proliferation of "hypertensive" lymphoblasts was significantly enhanced, although the PAF receptor expression was not significantly different between cell lines established from normotensive and hypertensive subjects [29] . Previous studies had shown that the PAF receptor of EBV-immortalized B lymphoblasts couples to pertussis toxin (PTX)-sensitive as well as to PTX-insensitive G proteins [30] . Upon preincubation of "normotensive" and "hypertensive" cell lines with PTX there was a strong, albeit not complete, inhibition of PAF-evoked Ca 2ϩ signals, suggesting the involvement of both G i as well as G q/11 type G proteins. Most remarkable, however, was the finding that the observed large difference between normotensive and hypertensive cell lines in terms of Ca 2ϩ signals was completely blunted upon treatment with PTX. This strongly suggested that signal transduction via PTX-sensitive G proteins was selectively enhanced in "hypertensive" cell lines. By quantification of PAF-stimulated [ 35 S]GTP␥S binding to permeabilized B lymphoblasts we could actually demonstrate an enhanced activation of PTX-sensitive G i -type G proteins in "hypertensive" B lymphoblasts [30] . This observation was strengthened in experiments in which the peptide mastoparan-7 was applied, the latter inducing a direct, receptor-independent activation of PTX-sensitive G proteins [31] . Mastoparan-7-stimulated G i -protein activation was, on the average, enhanced twofold in lymphoblasts from hypertensive individuals [30] .
Since these above findings were obtained in cell lines established from highly selected normotensive and hypertensive individuals, the question arose of whether enhanced G protein activation is a rare phenomenon that may contribute to the pathogenesis of essential hypertension in few patients only, or whether this abnormality can be frequently observed in essential hypertension. We therefore immortalized lymphocytes from independently selected hypertensive and normotensive individuals who had not been characterized previously in terms of NHE-1 activity. Larger PAF-evoked Ca 2ϩ signals mediated by G i proteins were more frequent in cells from hypertensive individuals compared to normotensive controls, and were independent of donor age, gender, or antihypertensive treatment (Fig. 1) . From these studies we concluded that enhanced G protein activation could constitute a pathogenetically important mechanism in 27 to 43% of individuals with essential hypertension [32] .
STUDIES ON SKIN FIBROBLASTS
The model of immortalized lymphoblasts allows alterations in signal transduction pathways that are ubiquitously expressed to be studied, such as receptor-G protein coupling, and the rapid growth of such cell lines provides a rich source of material for biochemical studies. Nevertheless, this model also has some inherent limitations. Although enhanced G protein activation in "hypertensive" cell lines was consistently found in repeated experiments conducted during a period of two years, we could not definitively rule out that this abnormality could potentially arise from an experimental artifact. It was still possible that the immortalization process induced by the EBV genome was different in cells from hypertensive and normotensive individuals and could, finally, result in the establishment of different cellular phenotypes. Furthermore, B lymphoblasts lack receptors that are important for blood pressure regulation or control of proliferation in the cardiovascular system. These limitations led us to establish cultures of primary skin fibroblasts from these previously characterized individuals. We hypothesized that fibroblasts from hypertensive individuals would display an increased DNA synthesis, enhanced Ca 2ϩ signals and inositol phosphate formation upon the stimulation of receptors that predominantly couple to PTXsensitive G proteins. In fact, skin fibroblasts from hypertensive individuals displayed an enhanced PTX-sensitive incorporation of [ 3 H]thymidine upon stimulation with lyso-phosphatidic acid (LPA), platelet-derived growth factor (PDGF) or serum [33] . PTX-sensitive Ca 2ϩ signals were increased upon stimulation of "hypertensive" cells with LPA, thrombin, PDGF, and sphingosine-1-phosphate (SPP), whereas PTX-insensitive Ca 2ϩ signals evoked by angiotensin II, endothelin 1, and bradykinin were not significantly different in skin fibroblasts from normotensive and hypertensive subjects [33] . Thus, these studies not only confirmed the hypothesis of a selectively enhanced cellular signaling by G i proteins in a group of patients with essential hypertension, but also suggested that this abnormality is simultaneously expressed in different cell types. It should be emphasized that signal transduction pathways mediated by G i -type G proteins are ubiquitously expressed, especially in cells of the cardiovascular system, such as vascular smooth muscle cells, endothelial cells, and cardiomyocytes. Therefore, it is tempting to speculate that enhanced G i protein activation will result in increased cellular responses, provided that receptors are activated which combine with these respective G protein subunits (Fig. 2) .
POTENTIAL REASONS FOR ENHANCED G I PROTEIN SIGNALING IN HYPERTENSION
The simplest cause for an increased G protein activation is an overexpression of G protein ␣ subunits. However, lymphoblasts from hypertensive subjects did not display an increased amount of PTX-substrate and GTP␥S binding capacity, and affinity was similar in lymphoblasts from normotensive and hypertensive subjects [29] , which argued against an overexpression of G␣ subunits in essential hypertension. Western blot analysis of G␣ expression in skin fibroblasts yielded a similar expression pattern of G␣ i2 and G␣ i3 in cells from hypertensive and normotensive individuals, G␣ O and G␣ i1 being obviously absent [33] . Similarly, we found no differences in the expression of the ␤ subunits G␤ 2 or G␤ 4 [33] . At present, there is no evidence that enhanced G i protein signaling in essential hypertension is caused by an overexpression of components of PTX-sensitive G proteins. Similar conclusions have been drawn from earlier studies on human platelet plasma membranes [34] .
At present we favor the hypothesis that mutations in G protein subunits may be responsible for the observed phenotype and, as cDNA and/or genomic sequences are available for most human ␣, ␤ or ␥ subunits, we are currently screening "candidate" G protein subunits for the presence of mutations. Thus far, mutations in the cDNAs encoding for the subunits G␣ i2 , G␣ i3 , G␤ 1 , and G␤ 2 could be excluded [33] . We speculate that functionally significant changes will most likely be detected in ␤␥ subunits, since ␤␥ subunits drastically enhance receptor-mediated G protein activation [35, 36] , and especially reduce the requirement of activated receptor for ␣ subunit activation. Other groups are currently trying to identify the gene loci responsible for enhanced Ca 2ϩ responses by linkage analysis using immortalized B lymphoblasts from established pedigrees. Preliminary analysis suggests that there is a significant linkage in one family to chromosome 16 [37] .
CONCLUSIONS AND PERSPECTIVES
Although the ultimate reasons for enhanced G protein signaling in patients with essential hypertension remain to be defined, the observations in this article fit well with those of others. Increased intracellular signal transduction was frequently observed in platelets from patients with essential hypertension and, for example, concentration. Enhanced activation of G proteins is predicted to cause a pronounced activation of these pathways, which may ultimately result in increased cell proliferation.
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increased Ca 2ϩ signals and enhanced activation of protein kinase C were frequently reported [38, 39] . Interestingly, such differences were not observed when platelets were stimulated with vasopressin [40] , which primarily activates PTX-insensitive G proteins in platelets. The "G protein hypotheses of essential hypertension" is also in complete agreement with the commonly held notion suggesting that high blood pressure results from an interaction between inherited and environmental factors. An attractive speculation is that enhanced G i protein reactivity alone is insufficient to result in essential hypertension in the absence of excessive stimulation of the affected signal transduction pathways. However, environmental factors such as emotional stress could drastically increase hormonal output, thereby contributing significantly to the development of high blood pressure on the genetic background of abnormal signal transduction. 17 
